NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
Back to search
Official data from USPTO
BESPAK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BESPAK
ST13
US500000098420336Class
5, 10, 40, 41, 42
Filing
98420336
Registration
7782740
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/07/2025
Trademark type
Word
Nice classes
5, 10, 40, 41, 42
Filing date
02/26/2024
Registration date
05/06/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
05/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
24
Owner location
Norfolk, GB
Examiner
GILLANI, MAHREEN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bespak Europe Limited
Representatives
Shannon Marie McKeon Dykema Gossett PLLC
Technical classification
Nice Classes
Class 5Class 10Class 40Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of infectiousviralbacterialmetabolicendocrineexocrinemuscularskeletalcardiovascularrespiratoryreproductivedigestiveexcretoryrenaloncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinallymphaticintegumentarynervoushormonaldermatologicalpsychiatric and immunological related diseases and disorders; Pharmaceutical productsrespiratory drugs for treating respiratory diseases and asthma; respiratory vaccines
Class 10
Drug delivery devices sold emptynasal inhalers for medical purposessold empty; pressurised metered dose inhalers (pMDI) for medical purposessold empty; nasal sprays for medical purposes; soft mist inhalers for medical purposessold empty; parts and fittings for all the aforesaid goods
Class 40
Custom manufacture of medical devices for others; custom manufacture of medical devices to the order and specification of othersinhalers and drug delivery devices sold emptypharmaceuticals; custom manufacture of componentsparts and fittings for all the aforesaid products; management of product lifecycles for othersin the nature of custom manufacturing of medical devices to the order and specification of othersinhalers and drug delivery devices sold emptypharmaceuticals; custom manufacturing of injection molded parts for others; custom manufacture of active pharmaceutical ingredients for others; custom manufacture of pharmaceuticals for others
Class 41
Provision of trainingteaching and educational services in the nature of workshopslecturesclasses and tutorialsall in the field of manufacturingengineeringchemistry and pharmaceuticals; training services in the field of injection molding manufacturing; advisoryconsultancy and information services relating to all the aforesaid
Class 42
Research and development of medical apparatus and instruments for others; research and development of inhalers and design of prototyping services; metrology services; Research laboratory testing and analysis services in the field of prototypingmetrologymanufacturingengineeringchemistrymedical and pharmaceuticals; product quality testing services; quality control advisory services namely regulatory quality control advisory of pharmaceuticalsactive pharmaceuticals ingredientsmedical apparatus and instrumentsinhalers and drug delivery productspharma and medical related products and apparatus and management of product lifecycles for otherscontinuing scientific research in the nature of conducting and managing clinical trials and trials of medical apparatus and instrumentsinhalers and drug delivery productspharma and medical related products and apparatus; consulting services in the field of pharmaceutical research and development; consulting services in the field of drug delivery devices; advisoryconsultancy and information services relating to all the foresaid
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2025
PUBO
PUBLISHED FOR OPPOSITION
01/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2024
GNRT
NON-FINAL ACTION E-MAILED
09/16/2024
CNRT
NON-FINAL ACTION WRITTEN
09/16/2024
DOCK
ASSIGNED TO EXAMINER
09/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2024
NWAP
NEW APPLICATION ENTERED
02/26/2024
Continuous trademark protection
Get notified about every new filing that threatens BESPAK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.